Paulo Costa

Former President & Chief Executive Officer at Novartis Corporation

Paulo Costa

Paulo Costa

Former President & Chief Executive Officer at Novartis Corporation

Overview
Career Highlights

Janssen Pharmaceutica NV
Novartis Corporation

RelSci Relationships

2394

Number of Boards

4

Birthday

1950

Age

70

Contact Data
Trying to get in touch with Paulo Costa? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Paulo Costa likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at MacroGenics, Inc.

Relationship likelihood: Strong

Chief Biotechnology Officer at Janssen Research & Development LLC

Relationship likelihood: Strong

Senior Advisor, Finance at Crinetics Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Celator Pharmaceuticals, Inc.

Relationship likelihood: Strong

Consultant at Sunesis Pharmaceuticals, Inc.

Relationship likelihood: Strong

Board Member & Directors at Amyris, Inc.

Relationship likelihood: Strong

Chairman at ViewPoint Therapeutics, Inc.

Relationship likelihood: Strong

Managing Partner at InterWest Partners, LLC

Relationship likelihood: Strong

Venture Partner at Genesys Capital Partners, Inc.

Relationship likelihood: Strong

Former Head-Oncology Therapeutic Area at Takeda Oncology Co.

Relationship likelihood: Strong

Paths to Paulo Costa
Potential Connections via
Relationship Science
You
Paulo Costa
Former President & Chief Executive Officer at Novartis Corporation
Education
MBA

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Executive Vice President, Global Franchise Development
1998 - Prior

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

President
1993 - 1998

Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium.

President & Chief Executive Officer
2005 - 2008

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Boards & Committees
Independent Director
2020 - Current

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.

Chairman, Board of Directors
2009 - Current

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe. Our innovative product candidates leverage our fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Our Dual-Affinity Re-Targeting (DART™) platform enables us to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Our Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells; and Our Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy.

Member, Group Operating Committee
1998 - Prior

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paulo Costa. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paulo Costa's profile does not indicate a business or promotional relationship of any kind between RelSci and Paulo Costa.